Done sou Salè H1B

Akèy › Metiyè › Molecular and Cellular Biologists › Rockville, MD

Molecular and Cellular Biologists nan Rockville, MD: Salè H-1B

89 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Rockville, MD. Salè baz medyàn ofri $103,000; mwatye mitan $86,618–$118,520.

Demann (LCA)89
Salè medyan ofri$103,000
Mwatye salè yo$86,618–$118,520
10yèm–90yèm pousantaj$72,862–$138,882

Pa nivo salè

Nivo revniSalè medyan
Nivo I (antre)$86,500
Nivo II (kalifye)$99,674
Nivo III (eksperyans)$116,927
Nivo IV (plen kompetans)$145,000

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

AnplwayèLCASalè medyan
National Institutes of Health, HHS19$105,000
Kelly Services, Inc.7$113,880
Leidos Biomedical Research, Inc.6$124,156
Psomagen Inc6$120,000
Innovative Cellular Therapeutics, Inc.4$71,074
Axle Informatics LLC4$113,555
Arcellx, Inc.4$125,000
Guidehouse Digital LLC3$93,000
Corixa Corporation3$89,100
University of Maryland Baltimore3$71,008
OriGene Technologies Inc.3$92,706
Champions Oncology, Inc.3$100,639
Contemporaries, Inc.2$144,027
Keygene Inc2$125,632
Horizon Therapeutics USA, Inc.2$103,520
Lonza Walkersville, Inc.2$102,038
J. Craig Venter Institute, Inc.1$74,000
PPD Development, L.P.1$90,189
Alten Technology USA, Inc.1$90,189
GAP Solutions Inc.1$185,000
Molecular Designs, LLC1$120,000
AAVnerGene Inc1$76,000
GlaxoSmithKline LLC1$93,787
The Geneva Foundation1$98,000
MaxCyte, Inc.1$180,500
Thermo Fisher Scientific Inc.1$131,976
Dexorgen, Inc.1$86,500
Corporate Employment Resources, Inc.1$69,430
Kaigene, Inc1$70,000
BioReliance Corporatoin1$117,000
BioReliance Corporation1$93,000
PediaMetrix Inc.1—

Tit travay

Pwonse H-1B nan Rockville, MD →

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).